Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perifosine +/- Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT00375791Phase 2Completed
- Sponsor
- COSCIENS Biopharma Inc.
- Start
- Dec 2005
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of perifosine in multiple myeloma (MM), sponsored by COSCIENS Biopharma Inc.. Started Dec 2005; status: completed.
02
Drugs
perifosine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00375791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00375791.